| LEADER |
01636nam a2200385 a 4500 |
| 001 |
ELB141048 |
| 003 |
FINmELB |
| 005 |
20201022193357.0 |
| 006 |
m o d | |
| 007 |
cr cn||||||||| |
| 008 |
120917s2013 flu sb 000 0 eng d |
| 020 |
|
|
|z 9781439855638 (hardcover : alk. paper)
|
| 020 |
|
|
|z 9781439855645 (e-book)
|
| 035 |
|
|
|a (OCoLC)1280141418
|
| 040 |
|
|
|a FINmELB
|c FINmELB
|d FINmELB
|
| 050 |
|
4 |
|a RS419.5
|b .M38 2013
|
| 082 |
0 |
4 |
|a 615.1/9
|2 23
|
| 100 |
1 |
|
|a Matson, Robert S.
|
| 245 |
1 |
0 |
|a Applying genomic and proteomic microarray technology in drug discovery /
|c Robert S. Matson.
|
| 250 |
|
|
|a 2nd ed.
|
| 260 |
|
|
|a Boca Raton :
|b Taylor & Francis,
|c 2013.
|
| 300 |
|
|
|a xv, 293 p.
|
| 504 |
|
|
|a Includes bibliographical references.
|
| 505 |
0 |
|
|a Omics & microarrays revisited -- The commercial microarray -- Supports & surface chemistries -- The arraying process -- Gene expression microarray-based applications -- Protein microarray applications -- Multiplex assays.
|
| 588 |
|
|
|a Description based on metadata supplied by the publisher and other sources.
|
| 590 |
|
|
|a Electronic reproduction. Santa Fe, Arg.: elibro, 2020. Available via World Wide Web. Access may be limited to eLibro affiliated libraries.
|
| 650 |
|
0 |
|a High throughput screening (Drug development)
|
| 650 |
|
0 |
|a DNA microarrays.
|
| 650 |
|
0 |
|a Protein microarrays.
|
| 650 |
|
0 |
|a Pharmacogenomics.
|
| 650 |
|
0 |
|a Proteomics.
|
| 655 |
|
4 |
|a Electronic books.
|
| 797 |
2 |
|
|a elibro, Corp.
|
| 856 |
4 |
0 |
|u https://recursos.uloyola.es/login?url=https://accedys.uloyola.es:8443/accedix0/sitios/ebook.php?id=141048
|
| 950 |
|
|
|a eLibro English
|